Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MileCell Biotechnology provides high-quality primary human and animal cell products and related CRO services to pharmaceutical companies and research labs. Their offerings support drug discovery through commercialization stages by supplying immune/human blood-derived primary cells, hepatic modeling solutions including hepatocytes/NPCs/subcellular fractions for ADME/toxicity testing, as well as specialty media/reagents such as their Kryogene™ cryopreservation solution. They do not develop their own therapeutic drugs but are an important enabler in the life sciences R&D ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MileCell Biotechnology.